HECTOROL*
Manufacturer Details
GENZYME CORPORATION INC.
Genzyme Corpn.Inc.
Compositions:
Doxercalciferol 0.5mcg/2.5mcg capsules,
Doxercalciferol 2mcg/ml injection soluion,
|
Strength
|
Rate
|
Packing Style
|
|
0.5mcg/2.5mcg
|
0.00
|
50s capsules
|
List of Related Indications:
- Hyperparathyroidsm/Vit D intox
List Of Drugs:
- Doxercalciferol- Fat-soluble Vitamins-(May 2008)
Indication Type Description:
Indication:
U.S.FDA APPROVED DRUGS FROM 01-01-08 TO 31-12-08
Drug name Indication Date of Approval
140. Doxercalciferol 0.5mcg/2.5mcg 29-05-08
soft gelatin capsules
For the secondary treatment of secondary
hyperthyroidism in patients with chronic
kidney disease on dialysis
168. Doxercalciferol (0.5/2.5mcg) Soft gelatin Capsule 05-08-08
For the treatment of scondary hyperparathyroidism in
patients with stage 3 or stage 4 chronic kidney disease
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
1.Doxercalciferol 0.5mg/2.5mcg 05-08-2008
Soft gelatin Capsule
Addl.Indication
For the treatment of Secondary Hyperthyroidism in patients with stage 3 or
stage 4 Chronic Kidney disease
2.Doxercalciferol 0.5/2.5mcg 29-05-2008
Soft Gelatin Capsule
For the treatment of secondary hyperthyroidm in patients with chronic
kidney disease on dialysis
Hyperparathyroidism
Dosages/ Overdosage Etc:
Dosage-
Chronic kidney disease stage Glomerular fitration rate Target iPTH (pg/mL)
Stage 3 30 to 59 35 to 70
Stage 4 15 to 29 70 to 110
Stage 5 < 15 (for dialysis) 150 to 300
